Press Release - 2026-04-29
PureTech Announces Annual Results for Year Ended December 31, 2025
Press Release - 2026-04-29
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
Press Release - 2026-04-27
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors